Preprogen is a privately held, women’s health company with the first-and-only, non-invasive, at-home gynecologic cancer cell collection screening kit, PadKit™. Preprogen aims to empower women at risk for endometrial cancer and other health issues and their physicians by giving them peace of mind knowing that Preprogen products provide a fast and non-invasive modern approach to cancer cell screening.
Preprogen’s novel cell science technology is a proven pathology-based screening technology that allows thousands of cells that naturally shed from all surfaces within the female gynecologic tract to be collected intact on a unique, comfortable, Interlabial Collection Pad™ (ICP) designed to fit the contours of a woman’s body. The ICP in PadKit™ is hypoallergenic, non-toxic, non-invasive, and should be worn on non-menstrual days, over a 4-6-hour timeframe during the day or overnight.
Preprogen’s cell science technology is at the heart of PadKit, the first-and-only at-home gynecologic cancer cell collection screening kit that allows for the discreet collection of thousands of cells from the gynecologic tract. After the pad is worn, it is placed into a transportation tube that contains a novel transport solution and mailed back to Preprogen’s lab. At the lab, the transport solution that includes gynecologic cell pellets are screened and analyzed for abnormal cells, signs of infection, and a variety of additional assays including genomic testing. Read More »
